» Articles » PMID: 32463024

Analytical Study of Biosynthesised Silver Nanoparticles Against Multi-drug Resistant Biofilm-forming Pathogens

Overview
Publisher Wiley
Specialty Biotechnology
Date 2020 May 29
PMID 32463024
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The emergence of the huge number of multi-drug resistant (MDR) bacteria requires an alternative to the drugs. Silver nanoparticles (AgNPs) are a strong candidate for this due to their bactericidal properties, which can be better concluded by understanding their morphology and chemistry. The study hypothesised that AgNPs synthesised using leaves of can be used to treat locally emerging MDRs forming biofilms on indwelling medical devices. Synthesised particles were characterised by methods like UV-visible spectroscopy, X-ray powder diffraction, scanning electron microscopy, transmission electron microscopy, and Zetasizer. Fourier transform infrared spectroscopy, and high-performance liquid chromatography were used to predict phytochemicals present in the leaves. The shape of particles is revealed to be relatively spherical, with average size to be around 10-100 nm. Phenolic compounds are attributed to the formation of nanoparticles, stability analysis shows particles to be stable, and zeta potential determined the surface charge to be -20.1 mV. Biosynthesised particles are found to possess efficient antibacterial activity MDR bacteria developing biofilms in medical devices; hence, it is concluded that based NPs can be used to develop a layer on implant-related medical devices. Toxicity evaluation against A594 cancer cells portrays AgNPs to be potential tumour reduction agents in a concentration-dependent manner.

Citing Articles

-Assisted Silver Nanoparticles: Biological Potential, Synthesis, Characterization, and Ecotoxicity.

Tharani M, Rajeshkumar S, Al-Ghanim K, Nicoletti M, Sachivkina N, Govindarajan M Biomedicines. 2023; 11(5).

PMID: 37239143 PMC: 10216392. DOI: 10.3390/biomedicines11051472.


In Vitro Genotoxicity Evaluation of an Antiseptic Formulation Containing Kaolin and Silver Nanoparticles.

Rodriguez-Garraus A, Azqueta A, Laborda F, Gimenez-Ingalaturre A, Ezquerra A, Lostao L Nanomaterials (Basel). 2022; 12(6).

PMID: 35335725 PMC: 8948953. DOI: 10.3390/nano12060914.

References
1.
Morones J, Elechiguerra J, Camacho A, Holt K, Kouri J, Tapia Ramirez J . The bactericidal effect of silver nanoparticles. Nanotechnology. 2010; 16(10):2346-53. DOI: 10.1088/0957-4484/16/10/059. View

2.
Shrivastava S, Bera T, Roy A, Singh G, Ramachandrarao P, Dash D . Retracted: Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology. 2023; 18(22). DOI: 10.1088/0957-4484/18/22/225103. View

3.
Chen X, Schluesener H . Nanosilver: a nanoproduct in medical application. Toxicol Lett. 2007; 176(1):1-12. DOI: 10.1016/j.toxlet.2007.10.004. View

4.
Reidy B, Haase A, Luch A, Dawson K, Lynch I . Mechanisms of Silver Nanoparticle Release, Transformation and Toxicity: A Critical Review of Current Knowledge and Recommendations for Future Studies and Applications. Materials (Basel). 2017; 6(6):2295-2350. PMC: 5458943. DOI: 10.3390/ma6062295. View

5.
Carlson C, Hussain S, Schrand A, Braydich-Stolle L, Hess K, Jones R . Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J Phys Chem B. 2008; 112(43):13608-19. DOI: 10.1021/jp712087m. View